Thursday, December 18, 2014

Leukemia Supplements- Table of Contents alert Volume 3 Issue S1

If you are unable to see the message below, click here to view.
Leukemia Supplements

New Views on the Role of Stem Cells in Myeloproliferative Diseases


Proceedings from the Stem Cells and Myeloproliferative Disorders Symposium, Providence, RI, USA

March 7th-8th, 2014

Guest Editor: Patrycja Dubielecka-Szczerba

Drugs that are currently in use to treat myeloproliferative diseases target mainly highly proliferative blast cells. We begin to understand that the stem cells are responsible for recurrence of the disease and we need to refine current therapies to target these slowly proliferating cells. This symposium focused on the role of stem cells in myeloproliferative diseases and relapse.

TABLE OF CONTENTS

Volume 3, Issue s1 (December 2014)

In this issue
Special Reports


Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Special Reports

Top

Altered microenvironmental regulation of CML stem cells

R Bhatia

Leukemia Supp 2014 3: S1-S2; 10.1038/leusup.2014.1

Full Text | PDF

Dissecting reprogramming, differentiation and conversion with network biology

G Q Daley

Leukemia Supp 2014 3: S3-S4; 10.1038/leusup.2014.2

Full Text | PDF

STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia

A M Eiring, I L Kraft, B D Page, T O'Hare, P T Gunning and M W Deininger

Leukemia Supp 2014 3: S5-S6; 10.1038/leusup.2014.3

Full Text | PDF

New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance

A Chorzalska and P M Dubielecka

Leukemia Supp 2014 3: S7-S8; 10.1038/leusup.2014.4

Full Text | PDF

Deconvoluting MLL1-dependent pathways in hematopoiesis and leukemogenesis

B P Mishra and P Ernst

Leukemia Supp 2014 3: S9-S10; 10.1038/leusup.2014.5

Full Text | PDF

Harnessing alloreactivity to achieve anti-leukemic responses

L D Fast

Leukemia Supp 2014 3: S11-S11; 10.1038/leusup.2014.6

Full Text | PDF

Reconsidering marrow stem cell cycle status: insights into an actively cycling hematopoietic stem cell population

L R Goldberg

Leukemia Supp 2014 3: S12-S13; 10.1038/leusup.2014.7

Full Text | PDF

Targeting leukemia stem cells with HDAC inhibitors and modulators of the DNA damage response

S Grant

Leukemia Supp 2014 3: S14-S15; 10.1038/leusup.2014.8

Full Text | PDF

Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?

H-J Kolb, H Schmetzer, C Schmid, I Bigalke, R Buhmann, A Moosmann, C Falk, S Reuther, F Schuster and A Borkhardt

Leukemia Supp 2014 3: S16-S17; 10.1038/leusup.2014.9

Full Text | PDF

Adult marrow hematopoiesis: a continuum of change

P J Quesenberry, L Goldberg, M Dooner, M Pereira and J Aliotta

Leukemia Supp 2014 3: S18-S18; 10.1038/leusup.2014.10

Full Text | PDF

Novel view on hematopoietic stem cell mobilization and homing

M Z Ratajczak

Leukemia Supp 2014 3: S19-S20; 10.1038/leusup.2014.11

Full Text | PDF

Adoptive immunotherapy for myeloid malignancies

J L Reagan

Leukemia Supp 2014 3: S21-S22; 10.1038/leusup.2014.12

Full Text | PDF

The polycythemia vera stem cell

J L Spivak

Leukemia Supp 2014 3: S23-S24; 10.1038/leusup.2014.13

Full Text | PDF

Myeloid differentiation and the leukemia-initiating cell

D G Tenen

Leukemia Supp 2014 3: S25-S26; 10.1038/leusup.2014.14

Full Text | PDF

Insights into the pathophysiology and therapy of myeloproliferative neoplasms from mouse models

R A Van Etten

Leukemia Supp 2014 3: S27-S28; 10.1038/leusup.2014.15

Full Text | PDF

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia Supplements. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: